Chronic obstructive pulmonary disease (COPD) is a complex and progressive disease associated with an overproduction of reactive oxygen species (ROS), circulating pro-inflammatory cytokines, and acute-phase proteins. This generalized oxidative/inflammatory status is accompanied by a downregulation of the cellular antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). Therapeutic agents that activate Nrf2 may have a pivotal role in the rebalance of the altered redox system. This chapter explores how the ozone can act as an endogenous redox modulator in the integrated treatment of COPD.
CITATION STYLE
Borrelli, E. (2019). The use of ozone as redox modulator in the treatment of the chronic obstructive pulmonary disease (COPD). In Oxidative Stress in Lung Diseases (Vol. 2, pp. 413–426). Springer Singapore. https://doi.org/10.1007/978-981-32-9366-3_18
Mendeley helps you to discover research relevant for your work.